Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
INSM
INSM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
INSM News
Insmed to Present at Upcoming Investor Conferences
2d ago
PRnewswire
Insmed to Present at Upcoming Investor Conferences
2d ago
Newsfilter
Stan Druckenmiller: The Influential Figure Behind Bessent and Warsh, Potential Candidates for Fed Chair
Feb 02 2026
Barron's
Definium Appoints Roger Adsett to Board of Directors to Drive Growth
Jan 29 2026
Yahoo Finance
Insmed to Present TPIP Study Findings at PVRI 2026 Congress
Jan 28 2026
PRnewswire
Insmed to Present TPIP Research Findings at PVRI 2026 Congress
Jan 28 2026
Newsfilter
Roth Initiates Insmed (INSM) at Buy with $212 Price Target, Sees Strong Sales Potential
Jan 23 2026
seekingalpha
Insmed Initiated at Buy by Roth with $212 Price Target, 32% Upside Potential
Jan 23 2026
CNBC
Earnings Momentum Review: BAX and Others Rated D
Jan 16 2026
seekingalpha
Alnylam Pharmaceuticals Down 8.1%, Worst Performer on Nasdaq 100
Jan 12 2026
NASDAQ.COM
Insmed (INSM) Stock Undervalued by 54.3% Based on DCF Analysis
Jan 11 2026
Yahoo Finance
US Stock Market Rallies, S&P 500 Hits All-Time High
Jan 10 2026
NASDAQ.COM
Trump Proposes $200 Billion Mortgage Bond Purchase to Boost Housing Demand
Jan 09 2026
NASDAQ.COM
Trump Proposes $200 Billion Mortgage Bond Purchase to Boost Housing Demand
Jan 09 2026
NASDAQ.COM
Nasdaq 100 Component Performance Analysis
Jan 09 2026
NASDAQ.COM
Insmed Outlines 2026 Roadmap with $172.7M Brensocatib Revenue Projection
Jan 09 2026
Benzinga
Show More News
